Media headlines about Validus (NYSE:VR) have been trending somewhat positive this week, according to Accern. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Validus earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned press coverage about the insurance provider an impact score of 47.1378050257483 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

Validus stock opened at $67.48 on Thursday. The company has a market capitalization of $5.33 billion, a PE ratio of -63.07, a P/E/G ratio of 1.77 and a beta of 0.99. Validus has a twelve month low of $67.37 and a twelve month high of $67.44. The company has a quick ratio of 0.97, a current ratio of 0.97 and a debt-to-equity ratio of 0.54.

Validus (NYSE:VR) last released its quarterly earnings results on Tuesday, May 1st. The insurance provider reported $0.53 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.09 by ($0.56). The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.32 billion. Validus had a negative net margin of 5.06% and a negative return on equity of 2.69%. The firm’s quarterly revenue was up 46.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.95 EPS. equities research analysts predict that Validus will post 4.22 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 30th. Stockholders of record on Tuesday, May 15th will be issued a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 2.25%. The ex-dividend date of this dividend is Monday, May 14th. Validus’s dividend payout ratio (DPR) is presently -142.06%.

A number of research analysts recently issued reports on the stock. Zacks Investment Research cut shares of Validus from a “buy” rating to a “hold” rating in a report on Wednesday, May 9th. Buckingham Research cut shares of Validus from a “buy” rating to a “neutral” rating in a report on Tuesday, February 13th. Keefe, Bruyette & Woods cut shares of Validus from an “outperform” rating to a “market perform” rating in a report on Monday, January 22nd. Finally, JMP Securities cut shares of Validus from an “outperform” rating to a “market perform” rating in a report on Tuesday, January 30th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $51.25.

In other news, Director Michael E.A. Carpenter sold 10,000 shares of the business’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $67.70, for a total value of $677,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, President Kean Driscoll sold 6,875 shares of the business’s stock in a transaction on Tuesday, May 15th. The stock was sold at an average price of $67.29, for a total transaction of $462,618.75. The disclosure for this sale can be found here. Insiders sold 30,625 shares of company stock valued at $2,068,363 in the last quarter. Corporate insiders own 2.33% of the company’s stock.

Validus Company Profile

Validus Holdings, Ltd. provides reinsurance coverage, insurance coverage, and insurance linked securities management services worldwide. It operates through three segments: Reinsurance, Insurance, and Asset Management. The Reinsurance segment underwrites property reinsurance products on a catastrophe excess of loss, per risk excess of loss and proportional basis; and aerospace and aviation, agriculture, composite, marine, technical lines, terrorism, trade credit, workers' compensation, and other specialty lines, as well as casualty and financial lines.

Insider Buying and Selling by Quarter for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with's FREE daily email newsletter.